Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Medtronic
Teva
QuintilesIMS
US Department of Justice
Cipla

Generated: March 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Veliparib

« Back to Dashboard

US Patents for Veliparib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Veliparib ➤ Sign Up Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Sign Up
Veliparib ➤ Sign Up 1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors Abbott Laboratories Inc. (Abbott Park, IL) ➤ Sign Up
Veliparib ➤ Sign Up 2-{(R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 2 Abbott Laboratories (Abbott Park, IL) ➤ Sign Up
Veliparib ➤ Sign Up 2-{(R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1 AbbVie Inc. (North Chicago, IL) ➤ Sign Up
Veliparib ➤ Sign Up Methods for treating ovarian cancer by inhibiting fatty acid binding proteins The University of Chicago (Chicago, IL) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Veliparib

Drugname Country Document Number Estimated Expiration Related US Patent
Veliparib European Patent Office 3131552 2034-04-16 ➤ Sign Up
Veliparib Japan 2017514806 2034-04-16 ➤ Sign Up
Veliparib New Zealand 629860 2034-04-16 ➤ Sign Up
Veliparib World Intellectual Property Organization (WIPO) 2015160868 2034-04-16 ➤ Sign Up
Veliparib Australia 2006235492 2025-04-11 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Chinese Patent Office
US Army
Harvard Business School
Teva
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.